Skip to main content
Equibles
STE logo

STE · STERIS plc · Metrics

Track STE — free

Use STE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$218.44 -6.15 (-2.74%) At close · Sep 8
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$21.90B
Shares
97.50M

STE metrics

102 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$218.44
Market cap
$21.90B

Price action

20 metrics
Price change (1W)
-3.9%
Price change (30D)
-6.0%
Price change (3M)
+5.8%
Price change (6M)
-2.6%
Price change (YTD)
-11.4%
Price change (1Y)
-7.7%
Trailing year
Price change (5Y)
+3.1%
52-week high
$268.65
52-week low
$199.40
Change from 52-week high
-16.4%
Change from 52-week low
+12.6%
Annualized volatility
25.4%
Annualized volatility (3M)
27.6%
Beta
0.5
RSI (14D)
40.2
Price vs SMA 50
-0.3%
Price vs SMA 200
-3.6%
Avg volume (3M)
750,946
Relative volume
0.8
Average dollar volume
$165.30M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
97.50M

Valuation

12 metrics
P / E (TTM)
28.3
Trailing earnings · reciprocal yield 3.5%
PEG ratio
0.6
EV / revenue
3.9×
reciprocal yield 25.9%
EV / EBITDA
14.3×
reciprocal yield 7.0%
EV / EBIT
20.4×
reciprocal yield 4.9%
P / sales
3.6×
reciprocal yield 27.6%
P / book
3.0
reciprocal yield 32.9%
FCF yield
4.2%
TTM · current market cap
Buyback yield
1.6%
P / FCF
23.7
reciprocal yield 4.2%
P / operating cash flow
17.0
reciprocal yield 5.9%
Earnings yield
3.7%

Historical valuation

8 metrics
P / E historical average (3Y)
52.5×
reciprocal yield 1.9%
P / E historical average (5Y)
59.1×
reciprocal yield 1.7%
EV / revenue historical average (3Y)
4.6×
reciprocal yield 22.0%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.2%
EV / EBIT historical average (3Y)
31.9×
reciprocal yield 3.1%
EV / EBIT historical average (5Y)
49.8×
reciprocal yield 2.0%
EV / EBITDA historical average (3Y)
18.8×
reciprocal yield 5.3%
EV / EBITDA historical average (5Y)
22.8×
reciprocal yield 4.4%

Dividends & buybacks

7 metrics
Dividend yield
0.9%
Trailing 12 months
Payout ratio
30.7%
Shareholder yield
2.7%
Dividend / share (TTM)
$1.95
Dividend growth YoY
-16.7%
Dividend growth streak
—
Last ex-dividend
2026-09-04

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
44.4%
Operating margin
18.9%
Trailing 12 months
Net margin
13.3%
Gross profit (TTM)
$2.68B
Operating profit (TTM)
$1.14B
Net income (TTM)
$805.00M
Trailing 12 months
Diluted EPS (TTM)
$7.93
FCF margin
15.3%
Effective tax rate
25.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$37.83

Growth

11 metrics
Revenue growth YoY
+7.3%
Year over year
Net income growth YoY
+12.8%
Revenue (TTM)
$6.04B
Trailing 12 months
EPS growth YoY
+51.4%
Shares change YoY
-0.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.4%
Revenue CAGR (5Y)
+13.8%
EPS CAGR (3Y)
+95.0%
EPS CAGR (5Y)
+11.4%
FCF CAGR (3Y)
+35.0%
FCF CAGR (5Y)
+16.6%

Quality

14 metrics
Return on equity
11.2%
Return on assets
7.5%
Debt / equity
0.3
Current ratio
1.9
EBITDA (TTM)
$1.63B
Free cash flow (TTM)
$925.60M
Quick ratio
1.4
Interest coverage
18.8
Net debt / EBITDA
0.9
Return on invested capital
9.8%
Trailing 12 months
Net cash
−$1.41B
Latest balance sheet
Cash & equivalents
$482.30M
Total assets
$10.74B
Total debt
$1.89B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.29B
Capital expenditures (TTM)
$362.90M
R&D (TTM)
$115.10M
SG&A (TTM)
$1.42B
Stock compensation (TTM)
$62.60M
R&D / revenue
1.9%
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
832
13F filer change QoQ
-15
Institutional ownership
97.3%

Short interest

3 metrics
Short interest
2.4%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.25M
Insider-sentiment score
45 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1757898 CUSIP G8473T100 13F (30d) 417 filings 413 filers Visit website Investor relations